Mira Pharmaceuticals IncNASDAQ:MIRA
- LAST PRICE1.3200
- TODAY'S CHANGE (%)0.0600 (4.7619%)
- Bid / Lots1.3400/ 1
- Ask / Lots1.3500/ 12
- Open / Previous Close1.2800 / 1.2600
- Day Range
- 52 Week Range
- Volume382,913
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MIRA |
|---|---|---|
| 09:32 ET | 4708 | 1.2601 |
| 09:35 ET | 5415 | 1.25 |
| 09:37 ET | 1601 | 1.23 |
| 09:39 ET | 1500 | 1.24 |
| 09:42 ET | 3200 | 1.2599 |
| 09:44 ET | 3200 | 1.27 |
| 09:46 ET | 2700 | 1.2899 |
| 09:48 ET | 4060 | 1.2821 |
| 09:50 ET | 200 | 1.29 |
| 09:51 ET | 3584 | 1.29 |
| 09:53 ET | 2800 | 1.29 |
| 09:55 ET | 11204 | 1.3048 |
| 09:57 ET | 28072 | 1.31 |
| 10:00 ET | 200 | 1.3189 |
| 10:02 ET | 1053 | 1.3104 |
| 10:04 ET | 800 | 1.3105 |
| 10:06 ET | 1926 | 1.3104 |
| 10:08 ET | 381 | 1.3194 |
| 10:09 ET | 1100 | 1.3101 |
| 10:11 ET | 3106 | 1.305 |
| 10:13 ET | 460 | 1.31 |
| 10:18 ET | 1700 | 1.305 |
| 10:20 ET | 1500 | 1.3199 |
| 10:22 ET | 549 | 1.319 |
| 10:24 ET | 724 | 1.32 |
| 10:27 ET | 700 | 1.3199 |
| 10:33 ET | 500 | 1.3108 |
| 10:38 ET | 2717 | 1.295 |
| 10:40 ET | 1126 | 1.305 |
| 10:42 ET | 750 | 1.3047 |
| 10:44 ET | 1300 | 1.305 |
| 10:49 ET | 4191 | 1.3001 |
| 10:51 ET | 2226 | 1.29 |
| 10:54 ET | 300 | 1.2985 |
| 10:56 ET | 2000 | 1.2903 |
| 10:58 ET | 2060 | 1.295 |
| 11:05 ET | 900 | 1.3 |
| 11:07 ET | 1600 | 1.295 |
| 11:09 ET | 1300 | 1.295 |
| 11:12 ET | 3276 | 1.295 |
| 11:14 ET | 100 | 1.295 |
| 11:21 ET | 200 | 1.29 |
| 11:23 ET | 200 | 1.297 |
| 11:27 ET | 2126 | 1.295 |
| 11:30 ET | 2600 | 1.2917 |
| 11:32 ET | 500 | 1.29 |
| 11:43 ET | 2210 | 1.2963 |
| 11:48 ET | 3500 | 1.2961 |
| 11:50 ET | 200 | 1.295 |
| 11:52 ET | 100 | 1.295 |
| 11:56 ET | 107 | 1.295 |
| 11:57 ET | 400 | 1.2901 |
| 12:01 ET | 1211 | 1.295 |
| 12:10 ET | 500 | 1.2921 |
| 12:12 ET | 9016 | 1.295 |
| 12:14 ET | 450 | 1.2906 |
| 12:15 ET | 1690 | 1.2908 |
| 12:19 ET | 1948 | 1.295 |
| 12:21 ET | 330 | 1.295 |
| 12:24 ET | 123 | 1.29 |
| 12:26 ET | 24860 | 1.3 |
| 12:28 ET | 8565 | 1.335 |
| 12:30 ET | 19962 | 1.3 |
| 12:32 ET | 300 | 1.3001 |
| 12:33 ET | 500 | 1.3066 |
| 12:37 ET | 2193 | 1.3 |
| 12:39 ET | 8148 | 1.295 |
| 12:46 ET | 410 | 1.295 |
| 12:50 ET | 7791 | 1.285 |
| 12:51 ET | 200 | 1.285 |
| 12:53 ET | 377 | 1.28 |
| 12:55 ET | 3224 | 1.28 |
| 01:04 ET | 1195 | 1.2706 |
| 01:06 ET | 100 | 1.275 |
| 01:08 ET | 200 | 1.275 |
| 01:11 ET | 100 | 1.28 |
| 01:15 ET | 206 | 1.275 |
| 01:18 ET | 100 | 1.27 |
| 01:33 ET | 100 | 1.28 |
| 01:36 ET | 690 | 1.275 |
| 01:42 ET | 100 | 1.275 |
| 01:44 ET | 400 | 1.2754 |
| 01:47 ET | 1000 | 1.2796 |
| 01:51 ET | 1000 | 1.2705 |
| 01:54 ET | 200 | 1.27 |
| 01:56 ET | 1287 | 1.275 |
| 02:00 ET | 4200 | 1.275 |
| 02:02 ET | 2317 | 1.265 |
| 02:03 ET | 210 | 1.265 |
| 02:05 ET | 123 | 1.261 |
| 02:07 ET | 4450 | 1.27 |
| 02:09 ET | 1900 | 1.2699 |
| 02:14 ET | 100 | 1.265 |
| 02:16 ET | 7164 | 1.265 |
| 02:21 ET | 3700 | 1.265 |
| 02:23 ET | 400 | 1.265 |
| 02:25 ET | 3035 | 1.275 |
| 02:27 ET | 1668 | 1.2794 |
| 02:30 ET | 100 | 1.275 |
| 02:39 ET | 1000 | 1.275 |
| 02:45 ET | 500 | 1.275 |
| 02:48 ET | 2722 | 1.2702 |
| 03:03 ET | 450 | 1.265 |
| 03:08 ET | 4290 | 1.26 |
| 03:10 ET | 2520 | 1.265 |
| 03:12 ET | 4313 | 1.265 |
| 03:14 ET | 600 | 1.265 |
| 03:15 ET | 3117 | 1.265 |
| 03:17 ET | 200 | 1.27 |
| 03:19 ET | 350 | 1.275 |
| 03:21 ET | 1295 | 1.27 |
| 03:28 ET | 4946 | 1.28 |
| 03:30 ET | 813 | 1.29 |
| 03:32 ET | 497 | 1.295 |
| 03:35 ET | 1654 | 1.29 |
| 03:37 ET | 1900 | 1.285 |
| 03:39 ET | 200 | 1.285 |
| 03:44 ET | 19129 | 1.28 |
| 03:46 ET | 526 | 1.285 |
| 03:50 ET | 100 | 1.285 |
| 03:51 ET | 200 | 1.285 |
| 03:53 ET | 300 | 1.285 |
| 03:55 ET | 100 | 1.285 |
| 03:57 ET | 838 | 1.29 |
| 04:00 ET | 26236 | 1.32 |
Nov 20, 2024
MIRA Reveals Innovative Phase I/IIa Protocol Design and Selection of Clinical Trial Site, from 7:45AM ET on Wednesday Nov 20, 2024 by Dow Jones
7:45AM ET on Wednesday Nov 20, 2024 by Dow Jones
Oct 28, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mira Pharmaceuticals Inc | 19.5M | -1.8x | --- |
CytoMed Therapeutics Ltd | 26.1M | -11.5x | --- |
UNITY Biotechnology Inc | 19.2M | -1.0x | --- |
Goldenwell Biotech Inc | 19.8M | -139.9x | --- |
Eom Pharmaceutical Holdings Inc | 19.3M | -3.9x | --- |
Enlivex Therapeutics Ltd | 19.9M | -0.8x | --- |
Company Information
MIRA Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical development company. The Company has two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. It holds exclusive license rights in the United States, Canada and Mexico for Ketamir-2, a patent pending oral ketamine analog under pre-clinical investigation to potentially deliver ultra-rapid antidepressant effects, providing hope for individuals battling treatment-resistant depression (TRD), major depressive disorder with suicidal ideation (MDSI) and potentially post-traumatic stress disorder (PTSD). Its oral pharmaceutical marijuana molecule, MIRA-55, is being studied for its potential to alleviate neuropathic pain, as well as anxiety and cognitive decline, symptoms commonly associated with early-stage dementia.
Contact Information
- Headquarters
- 1200 Brickell Avenue, Suite 1950 #1183MIAMI, FL, United States 33131
- Phone
- 813-369-5150
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Erez Aminov
- Chief Financial Officer, Treasurer, Company Secretary
- Michelle Yanez
- Director
- Matthew Del Giudice
- Director
- Michael Jerman
- Director
- Ned Macpherson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $19.5M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 14.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.73 |
Book Value | $0.30 |
P/E Ratio | -1.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
